Find a doctor with a specialty

Based on your search term '' we found results

Research at Adventist HealthCare

Current clinical trials

Currently Recruiting Clinical Trials

Check links below for more information and eligibility criteria for individual trials.

Breast Cancer

REDISCOVER 
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/​HER2- Breast Cancer (ReDiscover-2)
https://clinicaltrials.gov/study/NCT06982521 

VIKTORIA-2
A Randomized, Open-Label, Phase 3 Study of Fulvestrant and CDK4/6 Inhibitors With or Without Gedatolisib as First-Line Treatment in Patients With HR-Positive and HER2-Negative Advanced Breast Cancer
https://clinicaltrials.gov/study/NCT06757634

Germ Cell Cancer

P3BEP 
Phase 3 Accelerated BEP Trial: A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for participants with intermediate and poor risk metastatic germ cell tumours
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12613000496718 

OVARIAN CANCER

MEN2501-01
A Phase 1, First-In-Human Study Of Men2501, A Kif18a Inhibitor, As Monotherapy In Participants With Platinum-Resistant Ovarian Cancer
https://clinicaltrials.gov/study/NCT07226427

Prostate Cancer

WOMBAT

Working Out M0 Bipolar Androgen Therapy (WOMBAT)
https://clinicaltrials.gov/study/NCT06594926 

Bladder Cancer

LEGEND
A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients with BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients who are BCG Naïve or Received Incomplete BCG Treatment
https://clinicaltrials.gov/study/NCT04752722

Multiple cancers

CONTEXT
A Phase 1a/1b, First-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants with Recurring Triple Negative Breast, Colorectal, Urothelial Cancers
https://clinicaltrials.gov/study/NCT07545122

YF-N01-002
A Phase I/II Clinical Study Evaluating the Safety, Tolerability, and Efficacy of N-3C01 as Monotherapy and in Combination with PD-(L)1 Monoclonal Antibody in Patients with Advanced Malignant Solid Tumors
https://clinicaltrials.gov/study/NCT07639450

Cancer - Peripheral Neuropathy

INFOCUS
Peripheral Neuropathy in Chemotherapy-treated Patients: Predictors, Assessment strategies and Functional Outcomes: IN FOCUS (Identifying Neurological and Functional Outcomes in Cancer Survivors Study)

Kidney Disease / Renal

PYC-003-CL-001
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenously Administered PYC-003, a Peptide-phosphorodiamidate Morpholino Oligonucleotide Conjugate, in Healthy Adult Participants and Adult Participants With Confirmed PKD1 Mutation-associated Autosomal Dominant Polycystic Kidney Disease
https://clinicaltrials.gov/study/NCT06714006 

POSIBIL6ESKD

A Phase 2b / 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis
https://clinicaltrials.gov/study/NCT05485961 

RESOLVE
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events

Menopause

ADELE
A real-world observational study describing sleep outcomes among women with vasomotor symptoms associated with menopause using fezolinetant in Australia

CROHNS DISEASE

SIBERITE-2
A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study To Assess The Efficacy And Safety Of Induction Therapy With Ro7790121 In Patients With Moderately To Severely Active Crohn's Disease
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=23916&isClinicalTrial=True

VECTOR
An Interventional Study to Evaluate Treating to a Target of Transmural Healing in Patients with Moderately to Severely Active Crohn’s Disease (VECTORS)
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=22584&isClinicalTrial=True

For more information please contact us at SanTrials@sah.org.au.